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Major efforts have been put forth for the development of effective rotavirus vaccines including transgenic plant vaccines. Previous studies have
reported that rotavirus VP7 maintains its neutralizing immunity when it is transformed into the potato genome. The present study was aimed at
investigating the hereditary stability of VP7-transformed potatoes over fifty generations. The VP7 gene was stably transcribed and expressed in
potato cells as detected by RT-PCR and Western blotting. Humeral and mucosal responses were successfully induced in BALB/c mice fed with the
fiftieth generation transformed potato tubers. There were no significant differences in serum IgG and fecal IgA between the mice fed with the first
and fiftieth generation potatoes (P>0.05). Profiles of cytokines such as IFN-gamma, IL-2, IL-4, IL-5 and TGF-beta in immunized mice showed a
naive T-cells bias to Th1 and Th3 polarization. Moreover, specific CTL responses were also detected in C57BL/6 mice fed with transformed
potatoes. This research represents a significant step towards the development of rotavirus vaccines derived from a transgenic plant that can be
obtained by long-term and large-scale vegetative reproduction. To our knowledge, this is the first finding regarding vaccines derived from plants
that can be propagated for many generations.
© 2006 Elsevier Inc. All rights reserved.Keywords: Transgenic plant; Rotavirus VP7; Edible vaccine; CytokineIntroduction
Rotavirus is the most important cause of viral gastroenteritis
in young children and animals in the world (Parashar et al.,
2003). Most children have been infected with rotavirus at least
once by the age of 3, approximately six million children die
each year from diarrhea caused by a rotavirus infection in
developing countries (O'Ryan et al., 1994). Therefore, it is
imperative to develop safe and effective vaccines to fight
against rotavirus infections (Velazquez et al., 1996). The outer
capsid of rotavirus comprises a major glycoprotein VP7 and a
minor and protease-sensitive protein VP4. VP4 and VP7 can
induce neutralizing antibodies; therefore, they can be used as
targets for vaccine development (Buesa et al., 1999).Abbreviations: RV, rotavirus; CTB, subunit B of cholera toxin.
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doi:10.1016/j.virol.2006.07.045Major efforts have been devoted to the development of
effective rotavirus vaccines for humans and animals because the
discovery of the virus (Bernstein et al., 1999; Madore et al.,
1992). Live attenuated rotaviruses, rotavirus reassortants, virus-
like particles composed of rotavirus proteins VP4, VP6 and
VP7, DNA vaccines and rotavirus outer capsid protein (VP7 or
VP6) expressed in plants have all been investigated (Yu and
Langridge, 2001). Among them, transgenic plants expressing
therapeutic proteins are ideal vehicles for producing and orally
delivering protective antigens (Azad and Rojanasakul, 2006). It
has been speculated that a plant's cell wall delays the digestion
of plant-derived antigens; therefore, more antigens are absorbed
and presented to gut-associated lymphoid tissue (Ma et al.,
2005). We and others have demonstrated that plant cells can
express rotavirus antigenic proteins including VP7, in which the
proteins have been shown to be antigenic and immunogenic (Yu
and Langridge, 2001; Wu et al., 2003). In the present study, we
investigated the stability of a full-length rotavirus VP7 gene in
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which the characteristics of a specific immune response in mice
that were orally vaccinated with VP7-transformed potatoes
were also studied.
Results
Transgenic potatoes can be propagated over fifty
generations
We defined one generation as a two- to three-week period
from when the seedlings grew up to when they were transferred
to a fresh MS medium. We obtained over fifty generations of
VP7 transgenic potato progenies within five years since 2001
when we obtained the first generation of transgenic potatoes.
All of the seedlings maintained antibiotic characteristics (data
not shown) by placing the fiftieth generation seedlings on an
antibiotics selective MS medium (MS salts and vitamins, 20 g/l
sucrose, 8.5 g/l agar, pH 5.6, 50 μg/ml kanamycin and 300 μg/ml
cefotaxime). The stability of the transcription of a specific VP7
gene in the transformed potatoes was assessed by RT-PCR, as
previously reported. In the serial progenies of potatoes
transformed with VP7 gene, the amplification products were
observed to correspond to the recombinant gene, whereas mock-
transformed potatoes showed no transcription (Fig. 1A). The
quality of VP7 protein was evaluated by Western blotting usingFig. 1. Detection of VP7 gene transcription and expression level in different transgen
mRNA from different transgenic progenies; M, DNA molecular weight marker (San
transgenic potatoes); P, positive control (UV-inactivated RV from infected mammal
second, third, fourth, fifth, tenth, twentieth, thirtieth, fortieth and fiftieth generation
soluble protein from T10, T20, T30, T40 and T50. (C) Western blots of total soluble p
planted in a greenhouse in the first, second, third and fourth year, respectively.MA104 cultured rotavirus Wa as the standard (Fig. 1B). VP7
protein expressed in house-cultured, evergreen tubers was
subjected to Western blotting (Fig. 1C). The results indicated
that VP7 protein could maintain its antigenic property, which
were expressed in potatoes propagated from tubers or seedlings.
The difference in transformed potato progenies was assayed
by the ELISA, in which the analysis showed that recombinant
VP7 protein was expressed in the leaves at levels ranging from
3.6 to 4.0 μg/mg of the total soluble leaf protein (Fig. 2).
Compared to our previous results (Wu et al., 2003) in which the
amount of VP7 protein in tubers was equal to or slightly higher
than it was in the leaves, it was here too that the amount of VP7
protein in the tubers was approximately 40 μg/g.
These results demonstrated that the VP7 gene could be
inherited and stably expressed for more than fifty generations.
Induction of a humoral and mucosal immune response in orally
immunized mice
BALB/c mice were immunized orally on days 0, 7, 14, 21
and 42 with 2 g of the fiftieth generation transgenic potato
tubers. At different times, mouse sera and feces were
collected and analyzed for the presence of specific anti-VP7
antibodies (Figs. 3A and B). Antibodies from experimentally
immunized mice showed a strong response against VP7 as
shown by the ELISA. After the initial inoculation, the animalsic potato progenies. (A) Detection of VP7 gene transcription by RT-PCR. Total
gon, China); N, negative control (empty template); N′, negative control (mock
ian cell MA104 lysate); T1, T2, T3, T4, T5, T10, T20, T30, T40 and T50: the first,
VP7-transformed potato seedlings, respectively. (B) Western blots of the total
rotein from different progenies. G1, G2, G3 and G4: VP7-transformed potatoes
Fig. 3. Specific immune response in Balb/c mice fed with the fiftieth generation
VP7 transgenic potato tubers. (A) Sera IgG titers of mice fed with potato tubers.
Group1, mice fed with 2 g of mock-transformed potatoes, group2, mice fed with
2 g of VP7-transformed potatoes, group3, mice fed with 2 g of VP7-transformed
potatoes+adjuvant. GMTs are presented with standard errors. (B) Feces IgA
titers of mice fed with potato tubers. Group1, mice fed with 2 g of mock-
transformed potatoes, group2, mice fed with 2 g of VP7-transformed potatoes,
group3, mice fed with 2 g of VP7-transformed potatoes+adjuvant. GMTs are
presented with standard errors. (C) In vitro rotavirus neutralizing activity of anti-
VP7 responses in mice.
Fig. 2. Detection of VP7 protein in potato leaf extracts by an ELISA. N, negative
control (mock transgenic potatoes); P, positive control (UV-inactivated RV from
infected mammalian cell MA104 lysate); T10, T20, T30, T40 and T50: the tenth,
twentieth, thirtieth, fortieth and fiftieth generation VP7-transformed potato
seedlings, respectively. G1-4, VP7-transformed potatoes planted in a green-
house from the first to fourth year.
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with each booster. No response was detected in the mice that
were immunized with mock-transformed potatoes, even after
repeated inoculations (Figs. 3A and B). Mouse feces, urine
and saliva were also collected and detected as described
above (Fig. 3B). No significant levels of IgG and IgA were
observed in saliva or urine, whereas significant IgA levels
were observed in the feces from the mice immunized with
transgenic potato tubers (Fig. 3B). A neutralizing assay
conducted later on showed that the sera or feces derived from
mice fed with control transgenic plants had no neutralization
activity against rotavirus Wa. Significant levels of neutralizing
antibodies were, however, detected in the sera or feces
collected from mice fed with transgenic plants or transgenic
plants plus CTB (Table 1). These results confirm that
transgenic plants can induce functionally active anti-rotavirus
intestinal antibodies.
Cytokine profiles
Splenocyte proliferation is an important indicator for the
existence of humoral and cellular immunity. The spleen was
obtained from C57BL/b mice two weeks after the final
booster and was prepared into single cell suspensions.
Subsequently, the spleen cells from each mouse were isolated
and stimulated by using purified particles of UV-inactivated
rotavirus Wa.
Cytokines released from the spleen cells stimulated by UV-
inactivated rotavirus were measured in order to determine the
primed pathway of immune responses. IFNgamma, IL-2, IL-4,
IL-5 and TGF-beta were detected in the spleen cell supernatants.
Results showed in turn significant differences in the production
of IFN-gamma among the groups (P<0.05) (Fig. 4A), whereas
there was a slight increase in the production of IL-2 in the mice
fed with VP7-transformed potatoes or with VP7-transformed
potatoes as well as CTB compared to those fed with mock-
transformed potatoes (Fig. 4B). There were no significant
differences in the production of IL-4 (Fig. 4C) and IL-5 among
the groups (Fig. 4D). However, mice fed with transgenic
potatoes displayed a two- to fourfold increase in the TGF-betalevel (Fig. 4E) compared to the mice fed with mock transgenic
potatoes.
VP7-transformed potatoes induced a rotavirus-specific
cytotoxic T-cell immune response
To determine whether VP7-transformed potatoes stimulate a
CTL response, splenocytes obtained from C57BL/b mice were
restimulated with UV-inactivated rotavirus Wa in vitro, and
used as effector cells to lyse the target cells, namely, rotavirus
Wa-infected P815 cells. A significant specific lysis of the
target cells was observed in groups 5 and 6 (Fig. 5). The
control effector cells from the mice immunized with mock-
Fig. 4. Cytokine profiles of spleen cells stimulated by recombinant VP7 protein. Single cell suspensions of spleen cells were stimulated by 20 μg/ml UV-inactivated RV
Wa purified from culturedMA104 cells. After 48 or 96 h of culture, cell-free supernatants were collected and assayed for the presence of (A) IFN-gamma, (B) IL-2, (C)
IL-4, (D) IL-5 and (E) TGF-beta using a sandwich-ELISA. Data were presented as mean±SEM. Asterisk: P<0.05.
Fig. 5. Rotavirus-specific CTL response to rotavirus Wa-infected P815 cells in
the C57BL/6J (H-2Kb) mice fed with VP7 transgenic potatoes. Splenocytes
were obtained two weeks after the last booster and used as the effector cells in
the CTL assay. 51Cr-release assays were performed to assess the cytotoxicity
against rotavirus Wa-infected P815 cells at various E:T ratios. In the mice fed
with VP7 transgenic potatoes, or VP7 transgenic potatoes plus bacteria CTB, a
significant cytotoxicity to P815 cells was observed in a dose-dependent manner.
Approximately 50% specific lysis was observed at an effector to target (E:T)
ratio of 100:1, a figure higher than that of the groups fed with mock transgenic
potatoes. The data are representative of the three sets of experiments.
174 J.-T. Li et al. / Virology 356 (2006) 171–178transformed potatoes were not significantly lysed by the target
cells (Fig. 5).
Discussion
In light of the global impact of the rotavirus disease in
children, researchers have endeavored to develop vaccines that
stimulate immune responses induced by a natural rotavirus
infection; nevertheless, few vaccines were proven successful
(Ward et al., 1995; Michael, 1999). The mechanisms by which
natural rotavirus infection or immunization in turn elicits
protection remain poorly understood (Ward, 2003). In general, it
appears that serum IgA is a good predictor of clinical protection
after natural infection, but there is no or only a poor correlation
between serum IgA and vaccination with RRV-TV or other
rotavirus vaccines (Ward, 2003; Heath et al., 1997; Madore et
al., 1992). Interestingly, previous studies (Wu et al., 2003) along
with the present study have indicated that mice fed with
rotavirus VP7 transgenic plant were more likely to induce a
mucosal immune response (especially intestinal IgA) than a
humeral response (serum IgG). There were no significant
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only transgenic VP7 potatoes and transgenic VP7 potatoes plus
bacteria recombinant protein CTB, which is a kind of mucosal
adjuvant. The reasons explaining the absence of an immune
response difference have involved the method used (CTB were
dissolved in PBS and placed on the potato tuber slices before
fed, we can therefore suppose that the CTB protein was
digested by the gastrointestinal tract digestive juice after eating
the tubers) or the transgenic plant itself has the mucosal
adjuvant function because of its cell wall. A co-expressed
antigen and CTB are ideal. Furthermore, there were no
significant differences in serum IgG and fecal IgA between
the mice fed with the first and fiftieth generation potatoes
(P>0.05) (data not shown). The mechanisms involved are still
unknown. It may be of significance to further study the
correlation of a mucosal immune response and different
rotavirus vaccines such as transgenic plant vaccine and a live
attenuated vaccine. To express a rotavirus antigen-encoding
gene in plants is altogether a new strategy for vaccine
development, in which the resulting vaccine could be an ideal
mimic of a natural virus infection in terms of inducing an
intestinal IgA response.
Recently, plants were used as recombinant bioreactors to
express a number of proteins including drugs and potential
vaccines (Rigano et al., 2006; Youm et al., 2005; Aziz et al.,
2005; Pogrebnyak et al., 2005). Our results suggest that
transgenic potatoes remained stable for fifty generations. In
theory, plant transgenes mediated by Agrobacterium tumefa-
ciens are inherited stably and persistently according to
Mendelian law; nevertheless, to our knowledge no report is
available regarding how long they can be steadily inherited. The
present study addresses for the first time the stability of a
foreign gene in transgenic potatoes, which can propagate for
many generations.
We detected specific cytotoxic T lymphocytes (CTLs) in
C57BL/6 mice fed with VP7 transgenic potatoes, suggesting
cell immunity as another mechanism for an immune response
induced by a transgenic plant antigen. In fact, the mechanisms
for immunity against rotavirus infection are not completely
understood. Some believe that antibodies, especially local
immunity mediated by IgA, and induced by an active infection
is necessary (Bernstein et al., 1986), whereas others emphasize
that cell immunity such as specific CTLs plays an important role
(Franco et al., 1993).
CTLs are thought to be important in controlling primary
rotavirus infections and in the immune protection against
reinfection (Franco and Greenberg, 1995; Franco et al., 1993).
A role for CD8+ T-cells in protection from viral reinfection has
also been recognized (Franco et al., 1993; McNeal et al., 1995).
Experimental data on rotavirus infection in mice support the
hypothesis that rotavirus-specific CTL may protect against
disease. Rotavirus-specific CTLs are detected at the intestinal
mucosal surface in mice within the first week of infection
(Franco et al., 1997). CD8+ T-cells from rotavirus-immunized
adult mice protect suckling mice against rotavirus gastroenter-
itis in the absence of rotavirus-specific neutralizing antibodies
(Offit and Dudzik, 1989) and mediate the clearance of chronicrotavirus infection in SCID mice (Dharakul et al., 1990).
Therefore, our results require further researches.
Th1 cells are known to produce IFN-gamma and IL-2,
whereas Th2 cells produce IL-4 and IL-5, and Th3 cells
primarily produce TGF-beta (Street and Mosmann, 1991);
hence, the identification of the cytokine profiles of spleen cells
helps to determine the route by which rotavirus-specific
antibodies were produced. In addition, the development of the
CD4+ Th cell subset is essential for eradicating infectious
rotavirus. Moreover, Th2 cells generally promote the develop-
ment of selected humoral immunity, including IgG expression
(Amemiya et al., 2002). Previous studies indicated that the
expression of IgA in mucus is higher than that of serum IgG, but
little is known about the exact reasons (Wu et al., 2003). The
data presented here suggest that the immune responses
following oral immunization were provoked through the Th1-
and Th3-type routes. Th3-type response also tends to be
involved in this study in light of TGF-beta secretion. Th3 cells
are a subset of unique cells that primarily produce TGF-beta and
principally develop a mucosal immune response to orally
administered antigens. Th3 also has been found to have the
ability to induce IgA production (Sidonia et al., 2001). Because
the secretory cytokine TGF-beta may promote IgA secretion,
we hypothesize that the oral administration of a plant-derived
rotavirus vaccine induces a stronger IgA response, possibly due
to TGF-beta secretion. However, further researches are needed
to clarify the processes involved.
In conclusion, our results suggest that the VP7 gene-
transformed potatoes could be stably transcribed and expressed
for fifty generations, and that the immune responses following
oral immunization are mediated by Th1- and Th3-type routes.
Materials and methods
Production of VP7 transgenic potato tubers
The rotavirus antigen-encoding VP7 gene from a fecal isolate
of human rotavirus from a Chinese child with diarrhea was
inserted into plasmid pBI121 (Wu et al., 2003), in which the
recombinant was mobilized into A. tumefaciens (LBA4404),
and was then used to transform Solanum tuberosum L. cv.
Taiwanhong. The transformed Taiwanhong was cured of
A. tumefaciens and clonally propagated, in which Taiwanhong
line 4 was selected because of its high level of VP7 expression.
This line was then clonally propagated. Every two or three
weeks the seedling stem apex was cut and transferred to a fresh
MS medium. For every ten generations, some potato seedlings
were planted in soil to produce potato tubers and then collected
for further detection and the others were propagated on MS
medium. From 2001 to 2005, VP7-transformed potatoes were
propagated for over fifty generations.
Western blot analysis of a VP7 protein expression in transgenic
potatoes
Five micrograms of total soluble protein per sample were
added to 6 μl 6× SDS gel loading buffer (300 mM Tris–HCl,
Table 1
Summary of vaccination protocols
Group Treatment Mouse
type
Sample
size
1 2 g of mock-transformed potatoes Balb/c 5
2 2 g of VP7-transformed potatoes Balb/c 5
3 2 g of VP7-transformed potatoes+adjuvant* Balb/c 5
4 2 g of mock-transformed potatoes C57BL/6 5
5 2 g of mock-transformed potatoes C57BL/6 5
6 2 g of VP7-transformed potatoes+adjuvant* C57BL/6 5
*10 micrograms of bacterial CTB, i.e., subunit B of cholera toxin.
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blue, 60% glycerol), boiled for 10 min and placed on ice.
Purified rotavirus particles were used as the positive control.
The samples were centrifuged at 1200×g for 5 min at 4 °C, and
then loaded on SDS–polyacrylamide gel (10.5–14% Tris–HCl,
4% stacking, Bio-Rad). The gel was run at 30 mA for 3 h using
Tris–glycine running buffer (25 mM Tris, 250 mM glycine, pH
8.3, 0.1% SDS). The separated proteins were transferred from
the gel to a PVDF membrane (Roche) using a Mini-Trans-Blot
electrophoretic transfer cell (Bio-Rad) and left to run overnight
at 17 V. The membrane was then blocked with 2.5% dry milk in
PBST for Western blotting (PBS buffer plus 0.1% Tween 20) for
2 h at room temperature. After a brief wash in PBST, the
membrane was incubated with mouse monoclonal antibody
against VP7 (MAB8350, Chemicon), at a dilution of 1:1000 in
1% dry milk in PBST for 1 h at 37 °C. After a 15-min wash
followed by three washes for 5 min, the membrane was
incubated with horseradish peroxidase conjugated rabbit
polyclonal IgG antibody against mouse (Bioscience, Beijing),
diluted at 1:5000 in 1% dry milk in PBST. The membrane was
then washed in PBST for 15 min followed by three washes for
5 min. A protein assay was performed using ECL Plus
(Biosciences) according to the manufacturer's instructions.
Enzyme-linked immunosorbant assay analysis (ELISA)
Total soluble protein was extracted from freeze-dried
seedlings as previously described. The extracts were incubated
in the ELISA plate (Bioscience, Beijing) for 2 h at 37 °C,
followed by three washes with PBST by an ELISA (PBS plus
0.05% Tween 20) and blocking with 5% (w/v) dry milk in PBST
for 1 h at 37 °C. After another three washes, mouse anti-VP7
monoclonal antibody (MAB8350, Chemicon) (1:1000) was
added and incubated for 2 h at 37 °C. After another three washes
with PBST, the plate was incubated with peroxidase labeled
rabbit anti-mouse antibody (1:2000 in PBST, Bioscience,
Beijing), in which the final detection was performed using
TMB peroxidase substrate (Bio-Rad). The reaction stopped
after 5 min with 1 N H2SO4, in which the optical density was
measured at 450 nm using the Microplate Reader Thermo Max
(Bio-Rad).
Animals
Female BALB/c mice and female C57BL/6 mice (4–6 weeks
old) were purchased from the Beijing Laboratory Animal
Center (Beijing, China) and raised under clean conditions at
the Laboratory Animal Resources Center of Third Military
Medical University. Five mice were housed in an isolator cage,
to which air is supplied directly and then exhausted. The mice
were raised for 1 week before they were used for an experiment.
Then, each mouse was placed in an individual cage before
feeding the tubers. The mice had free access to sterile water and
standard mouse chow except for the transgenic potatoes. Mice
were monitored on a daily basis for signs of weight loss and
other conditions. There were five mice subjected to each
treatment.Vaccination
The protocols are summarized in Table 1. Before an oral
administration of potatoes, the mouse was fasted for 8 h. Then,
the mouse was fed a diet containing 2 g of potato tubers (with
80 μg of plant-derived VP7) for 16 h.
Detection of VP7-specific immune responses
VP7-specific serum IgG and fecal IgA titers were measured
and a plaque reduction neutralization assay was performed. In
brief, 96-well ELISA plates (Corning, NY) were coated with
200 μl of 5 μg/ml rotavirus particles purified by sucrose
gradient density centrifugation (about 300 ng VP7 protein per
well) in PBS and incubated overnight at 4 °C. After three
washes with PBST for an ELISA (PBS, pH 7.4, plus 0.05%
Tween 20), plates were blocked with fetal bovine serum (FBS)
in PBS (1:10) and incubated for 1 h at 37 °C. After three
washes with PBST, serum was serially diluted twofold in the
plates using FBS and starting at 1:100. The plates were
subsequently incubated for 1 h at 37 °C before being washed
three times with PBST and incubated with horseradish
peroxidase (HRP) conjugated goat anti-mouse-IgG1 (Southern
Biotech), at a dilution of 1:4000 in blocking buffer (1:10
dilution FBS in PBS), for 1 h at 37 °C. For IgG, the plates were
incubated with HRP conjugated rabbit anti-mouse-IgG anti-
body (Bioscience), at a dilution of 1:2000 in blocking buffer,
for 1 h at 37 °C. After washing with PBST fourfold, the
detection was performed using TMB peroxidase substrate (Bio-
Rad) for 5 min. The reaction was stopped with 1 N H2SO4, and
then the absorbance was measured at 450 nm using the
Microplate Reader Thermo Max (Bio-Rad). Titers were
estimated as the reciprocal of the maximum dilution of serum
giving in turn an absorbance reading of 0.1 U after the
subtraction of non-specific binding in serum from non-treated
animals (negative control).
Fecal samples were prepared by adding 5 ml of extraction
buffer (PBS, 0.1% Tween 20 and 10 μg/ml leupeptin) into a
gram of feces. Suspensions were kept for 30 min at 4 °C and
thoroughly homogenized with a QBiogene Fast Prep machine
for 1 min. After incubation for another 30 min at 4 °C,
suspensions were centrifuged for 20 min at 16,000× g
(Eppendorf), at 4 °C. The supernatant was collected and
centrifuged again at 16,000×g at 4 °C for 1min. The supernatant
was collected and immediately analyzed by an ELISA or stored
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sample was tested using the Bradford Assay (Bio-Rad). Twofold
serially diluted samples of TSP, starting at 50 μg, were applied to
the plates (previously coated with rotavirus and blocked as
described in the section of serum samples) and incubated for 1 h
at 37 °C. After washing in triplicate with PBST, plates were
incubated for 1 h at 37 °C with an anti-mouse-IgA antibody
(Sigma-Aldrich) diluted 1:1000 in a blocking buffer. Detection
was performed as previously described for serum samples.
Neutralization assay
For the determination of neutralizing anti-HRVantibodies in
sera and stools, sera and stools obtained from mice were tested
by a microneutralization assay as described previously (Wu et
al., 2003). Briefly, sera and stools from mice were heat-
inactivated at 56 °C for 30 min and incubated with Wa strain
rotavirus. A reduction in the number of HRV-infected cells of
greater than 60% with respect to the number in control wells
was indicative of neutralization. Neutralizing titers were
expressed as the reciprocal of the highest dilution of sera or
stools yielding neutralization, as described.
Cytokine detection
In order to measure cytokine secretion, single splenocyte
suspensions were prepared two weeks after the final booster.
After 48 or 96 h of culture, cell-free supernatants were harvested
and assayed. Supernatants were then screened for the presence
of IFN-gamma, IL-2, IL-4, IL-5 and TGF-beta using sandwich-
ELISA detection systems according to the instructions of the
manufacturer (BMS) as described above.
Cytotoxicity assay
A standard 51Cr release assay (Heath et al., 1997) was used to
measure CTL activity. As target cells, MC57 or P815 cells were
infected with 100±130 m.o.i. of rotavirus Wa. After 5 h of
incubation at 37 °C, the cells were trypsinized, washed, counted,
centrifuged and labeled for 1 h at 37 °C with 50± 100 mCi of
Na51CrO4 (Zhongshan Company, Beijing, China). The cells
were then washed in triplicate and placed in 96-well plates
(10,000 cells/well). Effector cells were added at the appropriate
concentrations in order to obtain various effector: target cell
ratios (E:T) (12.5:1, 25:1 and 50:1) in a total volume of 200 μl.
Spontaneous and total releases of 51Cr were calculated by
incubating target cells in each experiment with medium only, or
with 10% Triton X-100. After 5 h of incubation at 37 °C, the
plates were centrifuged at 500×g for 5 min and 100 ml of
supernatant was removed from each well and the gamma
radioactivity was measured using a gamma counter (Spectra-
Gamma, Packard Instruments Co., Meriden, CT). The percen-
tage of specific lysis was calculated as 100×[(cpm released by
CTL−cpm of spontaneous release) / (cpm of total release−cpm
of spontaneous release)]. A response was considered positive
when it was at least twice the lysis value of the control target
cells (mock-infected and/or rotavirus-infected cells). The resultswere obtained from two or three experiments and each
experiment was performed in triplicate. Results are expressed
as mean±standard error of the mean (SEM).
Statistical analysis
All statistical analyses were performed using the software
SPSS 11.0 for Windows. A two-tailed Student's t test was used
to compare the differences in mean values between groups. A
P value less than 0.05 was deemed statistically significant.
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